Skip to main content

RIBER: Order for a Research MBE machine in the United States

Press release

Order for a Research MBE machine in the United States

Bezons, February 10th, 2022 – 8:00am – RIBER, the global leader for Molecular Beam Epitaxy (MBE) equipment serving the semiconductor industry, is announcing an order for a research MBE system in the United States.

Professor G. Salamo, director of Nanoscience and Engineering Institute from University of Arkansas, USA, has ordered Riber best seller Compact 21, 3’’ research system. This fifth Riber MBE system will complete the existing modutrac line. Apart from III-V nanoscale growths, this new reactor will also permit studies of epitaxial Si/Ge/Sn/Pb heterostructures focused on band engineering via Sn incorporation and strain manipulation.

Compact 21, model TM, is compatible with existing modutrac MBE32 line. Compact 21 TM is a very attractive solution to increase MBE capability, with 10 source ports symmetrically arranged, large number of in-situ instrumentation ports, and more flexibility in pumping configuration, compared to the MBE32/2300. One can easily add this system to an existing line, like University of Arkansas does, or switch from an old Riber MBE32/2300 reactor to this system while keeping a maximum of equipment: manipulator, cells, instrumentation, pumps, etc.

This order will be delivered in 2022.

Philippe Ley, CEO of Riber
University of Arkansas Nanoscience and Engineering Institute is a 25-year-old Riber customer. It has always been a pleasure to work with Prof. Salamo and his team. Their high level of expertise, understanding and involvement in each discussion and at each step of the project has been really appreciated by all the Riber project team. We believe that the technological issues addressed here will enhance epitaxy processes and enable Arkansas MBE-STM1 facility to maintain state-of-the-art results.

Professor Greg Salamo
We are looking forward to receiving this new system. It will allow us to develop new SiGeSnPb technology not possible with current MBE systems. Through many cycles of discussion, we arrived at a method to control the temperature of growth at low temperatures of 100°C to 300°C, which will be tested with emphasis on our requested specs. As in the past, when we work with Riber to integrate STM, Riber scientists were amazing helpful, including modeling different designs, and we look forward to this and further collaborations with Riber.

About RIBER

RIBER is the global market leader for MBE – molecular beam epitaxy – equipment. It designs and produces MBE systems and evaporators for the semiconductor industry. It also provides technical and scientific support for its clients, maintaining their equipment and optimizing their performance and output levels. Through its high-tech equipment, RIBER performs an essential role in the development of advanced semiconductor systems that are used in numerous consumer applications, from information technologies to 5G telecommunications networks, OLED screens and next-generation solar cells.
RIBER is a BPI France-approved innovative company and is listed on the Euronext Growth Paris market (ISIN: FR0000075954).
www.riber.com

Contacts

RIBER
Stéphane Berterretche
tél. : +33 (0)1 39 96 65 00
invest@riber.com
CALYPTUS 
Cyril Combe
tel: +33 (0)1 53 65 68 68
cyril.combe@calyptus.net


1 Scanning Tunneling Microscopy

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.